Clinical Trial Update: Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up

View source ↗

Summary

Ongoing post-market clinical follow-up study of the Lifetech CeraFlex ASD Closure System for atrial septal defects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect

Drugs mentioned

• Lifetech CeraFlex ASD Closure System

Snippet

Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. | Conditions: Atrial Septal Defect | Status: RECRUITING